| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082408 | Drug Discovery Today: Disease Models | 2007 | 6 Pages |
Abstract
Diabetic neuropathy is not a single but several different pathogenic mechanisms leading to several symptoms. Diabetic animal models have been extensively used to characterize these mechanisms to evaluate potential treatments in humans. We reviewed the chronology of the pathogenic process underlying diabetic neuropathy occurring in several in vivo diabetic animal models in either type 1 or type 2.
Section editors:Cord Dohrmann, Matthias Austen, Ursula Kreuzberg – DeveloGen AG, Marie-Curie-Strasse 7, 37079 Goettingen, Germany
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Dominique Sigaudo-Roussel, Bérengère Fromy, Jean Louis Saumet,